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BACKGROUND:  Malignant  peripheral  nerve  sheath  tumor  is  an  uncommon  tumor  of the  peripheral  nerves.
The  commonest  presenting  symptom  is  soft  tissue  mass  and  pain  with  local  neurological  ﬁndings.  Imaging
modalities  are  unhelpful  in  making  a reliable  diagnosis.  Treatment  is radical  resection  with  adequate  clear
resection margins.  Radiotherapy  improves  the  local  control,  but  the prognosis  remains  poor  especially
in  those  with  divergent  differentiation.
SUMMARY:  A  23-year-old  man  with  no  history  of  neuroﬁbromatosis  presented  with  a  swelling  on the
back  which  has  been  gradually  increasing  in size  and  causing  him  discomfort.  The  tumor  was  surgically
excised  and  the  histopathological  examination  revealed  malignant  peripheral  nerve  sheath  tumor  with
extensive  osseous  and  cartilaginous  differentiation.  He  developed  pulmonary  metastases  one  year  after
the surgical  resection.  Pulmonary  metastatectomy  was  therefore  performed  and  the histopathology  of the
metastatectomy  specimen  revealed  metastatic  malignant  peripheral  nerve  sheath  tumor,  but without  any
osseous or  cartilaginous  differentiation.  He  remained  well  with  no recurrence  or metastases  at  9-month
follow-up.
CONCLUSION:  Malignant  peripheral  nerve  sheath  tumor  is  a malignant  tumor  that  behaves  aggressively
despite  adequate  radical  resection.  This  case also  illustrates  extensive  osseous  and  cartilaginous  divergent
differentiation  of  the  primary  tumor  which  was  surprisingly  absent  in the  metastatic  lesions.  This ﬁnding
warrants  further  research.
©  2016  The  Authors.  Published  by Elsevier  Ltd  on  behalf  of IJS  Publishing  Group  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
Malignant peripheral nerve sheath tumor (MPNST) is an uncom-
on soft tissue sarcoma that arises from the peripheral nerves.
t may  originate from normal nerves or pre-existing plexiform
euroﬁbromas and perineuriomas. The tumor is sporadic in the
ajority of the cases but it is associated with neuroﬁbromatosis
ype 1 (NF1) in 20%–50% of the cases especially in younger patients
1,2]. MPNST commonly affects the trunk and extremities and less
ften the head and neck area [3]. The tumor is well known for its
ggressiveness and tendency to metastasize to distant organs espe-
ially lung and bones. The local control of the tumor is best achieved
y radical surgical resection and adjuvant radiotherapy. However,
his does not prevent early development of distant metastases.
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We  report herein a case of MPNST of the trunk with bone
and cartilage differentiation in a young man  who had no clinical
features of neuroﬁbromatosis type 1 (NF-1) and who developed
pulmonary metastases one year after surgical resection and adju-
vant radiotherapy. Of interest is that the metastatic lesions in this
case – unlike the primary tumor – did not exhibit any divergent
osseous or cartilaginous differentiation.
2. Case report
A 23-year-old male presented to the surgical clinic with a
swelling over the left side of his back. The swelling was noticed
several years earlier, but was small and painless. He was exam-
ined at another facility and was advised to observe. The swelling
became larger, harder and uncomfortable over the recent months
and was  therefore referred as a case of ‘back lipoma’. There was no
signiﬁcant past surgical or medical history and he denied any fam-
ily history of neuroﬁbromatosis. Examination revealed a hard oval
swelling (7 × 4 cm)  just to the left of the upper lumbar spine which
was partially mobile. Routine blood tests were within normal range
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. Magnetic resonance imaging coronal view (panel A) and sagittal view (panel B) showing clearly the lesion with some calciﬁcation.
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sig. 2. An operative view showing the lesion as it was  dissected from the surroundi
ith  a smooth surface.
nd review of the computed tomography (CT) and magnetic reso-
ance imaging (MRI) scans which were done outside conﬁrmed
he presence of a soft tissue mass which was unlikely to be a
ipoma (Fig. 1). Fine needle aspiration cytology (FNAC) was  offered,
ut refused by the patient and hence surgical resection of what
ppeared to be an encanpsulated mass (Fig. 2) was carried out.
Pathological examination revealed a soft tissue mass measur-
ng 7 × 4 × 2.5 cm,  with soft myxoid areas and ﬁrm hard areas.
istologically, the tumor exhibited areas of malignant spindly mes-
nchymal cells with brisk mitotic activity within loose myxoid
troma and foci of tumor necrosis. In addition, areas with marked
steosarcomatous and chondrosarcomatous differentiation were
dentiﬁed (Fig. 3A–D). However, no rhabdomyosarcomatous or
landular differentiation was noted. Immunohistochemical stains
how focal nuclear staining of the malignant spindly cells for S100cture (Panel A). Panel B showing the excised mass which looked well encapsulated
protein but they were negative for smooth muscle actin, desmin
and myogenin. These ﬁndings conﬁrm the tumor as MPNST. Based
on the pathological ﬁndings, CT scan of the chest, abdomen and
pelvis was  performed and this excluded presence of distant metas-
tases. Also, neurosﬁbromatosis type I (NF1) gene sequencing was
ordered at a referral laboratory and found to be negative.
The case was  discussed in the multidisciplinary tumor board and
adjuvant radiotherapy was recommended. After ﬁnishing all radio-
therapy sessions, he remained well with no evidence of recurrence
or metastases at 6- and 9-month follow-ups. However, at 12-month
follow-up a body combined 18F-ﬂuorodeoxyglucose–positron-
emission tomography and CT (FDG–PET–CT) scan showed a right
lung metastatic nodule with avid FDG activity (SUVmax 6.8) (Fig. 4).
Another smaller nodule was also noted in the anterior aspect of
the left upper lobe. The patient underwent right mini-thoracotomy
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Fig. 3. Micrograph of the resected lesion showing an area of the tumor featuring spindle cells within loose stroma with associated nuclear atypia and scattered mitotic ﬁgures
(panel  A; H&E stain. ×200). The microscopic ﬁeld in panel B shows the presence of bony trabeculae surrounded by large malignant hyperchromatic, multinucleated bizarre
cells  (H&E stain ×200). Panel C shows the tumor acquiring a pleomorphic undifferentiated (malignant ﬁbrous histiocytoma-like) pattern (H&E stain ×200). Panel D shows
an  area with chondrosarcomatous differentiation (H&E stain ×200).
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wFig. 4. The metastatic lesion in the right lung as it appeared on CT sca
nd upper lobe lung metastesectomy and after 2 months left mini-
horacotomy and lung metastatectomy was also performed. The
istology of both metastatectomies conﬁrmed metastatic MPNST
ith a pure spindle cell sarcomatous pattern but without osseous
r cartilaginous elements. He remained well after the metastate-
tomy with no evidence of further metastases at 9–month follow
p.
. Discussion
Malignant peripheral nerve sheath tumor (MPNST) accounts for
bout 5% of all soft tissue sarcomas. The tumor is associated with
euroﬁbromatosis type 1 (NF1) especially in younger patients [1,2].
owever, this was not the case in this patient as he exhibited no fea-
ures of neuroﬁbromatosis and screening for NF1 gene sequencing
as negative.t panel) and PET scan (right panel) with an avid uptake (SUVmax 6.8).
The presenting symptoms are often non-speciﬁc and arise as a
result of direct nerve invasion or pressure effect on the surrounding
tissues. The commonest presentation is soft tissue mass, followed
by pain and local neurological ﬁndings [2]. Unfortunately, more
than 15% of cases have distant metastases at the time of presen-
tation [1]. It has been suggested that sudden change in tumor size
and increase in pain intensity indicate malignancy [4].
Imaging studies are usually not helpful in making a reliable
diagnosis but large tumor size (>5 cm)  with ill-deﬁned margins,
fat plane invasion and surrounding edema may  suggest MPNST
[5]. Nevertheless, deﬁnitive diagnosis can only be made after exci-
sional biopsy [1]. PET-CT scan can distinguish between MPNST and
neuroﬁbroma and it is also – as in the present case – helpful in
identifying distant metastases during follow-up.
On gross examination, MPNST tend to be ﬁrm (Fig. 2) and
microscopically it is highly cellular and comprised of spindle
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itotically-active cells which are weakly S100 positive. This weak
ositivity is consistent with dedifferentiation from Schwann cells.
PNSTs have the capacity in about 15% of cases to exhibit
ivergent differentiation to various elements other than Schawa-
ian or ﬁbroblastic differentiations [6]. Such heterotopic elements
nclude osteosarcoma, chondrosarcoma, angiomsarcoma and rhab-
omyosarcoma. It is rare to have divergent differentiation of two  or
ore components in a single MPNST. However, MPNST cases with
 and even 6 differentiation patterns have been reported [7,8]. By
ar bone and cartilage are the most common elements [9–11] as
xhibited in this case. Of great interest, there was no such divergent
lement detected in the pulmonary metastatic lesions. We  can offer
o explanation to this interesting pathological ﬁnding but it war-
ants future research and analysis. It is believed that this divergent
ifferentiation may  be associated with poor prognosis [11,12] as
5% of patients die of the tumor after a mean survival of 2 years only
6]. Other differentiations include malignant triton tumor (MPNST
ith rhabdomyosarcomatous differentiation); a highly malignant
umor containing embryonic striated muscle components, and is
ssociated with very poor prognosis [13].
Treatment is better drawn by a multidisciplinary team and it
nvolves radical surgical resection of the tumor with sufﬁcient wide
argins to achieve a potentially curative operation [13–15] For
ead and neck lesions wide excision may  be hindered by the close
roximity of vital organs. Adjuvant or neoadjuvant radiotherapy
mproves local control especially when wide excision alone is dif-
cult. However, R0 resection can be achieved in 70% of cases only
14,15].
Prognosis is generally poor mainly due to high local recurrence
nd distant metastases. Some poor prognostic signs include truncal
ocation, tumors larger than 5 cm in size, inability to achieve tumor-
ree margins, and higher tumor grade. Other poor prognostic factors
re the association with NF1, older age, rhabdomyosarcomatous
ifferentiation and distant metastases at the time of diagnosis. The
-year survival remains poor ranging from 35 to 65% [1,2,13–16].
This case highlights the fact that MPNST is an aggressive tumor
specially in younger age group even if there is no association
ith NF1 gene. Distant metastasis may  appear within 1 year of
adical R0 resection of the primary tumor and divergent differ-
ntiation is associated with poor prognosis. Moreover, metastatic
esions of MPNST may  not exhibit divergent differentiation despite
ts presence in the primary lesion; the impact of this ﬁnding on the
rognosis is yet to be determined.
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